history of glp-1 agonists glucagon-like peptide-1 receptor GLP-1R Agonists for Weight Loss
Description
Another systematic review of randomized trials found that muscle-related indices often exceeded the usual benchmark of about 25% of weight loss coming from fat-free mass
We used version 2 of the Cochrane risk-of-bias tool for randomised trials to assess risk of bias for the primary outcome
Starting in July 2026, some people with Medicare will be eligible for Medicare coverage of certain weight-loss medications through the new Medicare GLP1 Bridge Program
See if you qualify
Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss
